Carotid Artery Stenting before CABG: A Better Alternative to Treat Concomitant Coronary and Carotid Artery Disease

Background: Atherosclerosis of the coronary and carotid arteries can be fatal.Stroke is a serious complication of coronary artery bypass graft surgery, and carotid artery dysfunction is a major risk factor for stroke (CABG).Methods: Patients who met the criteria for CABG were included in this prospective cohort study of those with severe carotid artery stenosis (>70%).Complications 30 days after stenting, neurological complications during cardiac surgery, rates of myocardial infarction (MI), and rates of death were among the outcome indicators evaluated.Results: according to outcome the mean duration of follow-up was 31.23 (±18.27SD) with range (1-60) months, according to early adverse event there were 1 (0.5%) with cardiac death, 1 (0.5%) with major Ipsilateral Nonfatal Strokes, 2 (1%) with minor strokes, there were 30 cases of cardiac death (15%), 2 cases of neurological death (1%), 4 cases of death for other reasons (2%), 2 cases of major ipsilateral nonfatal stroke (1%), 1 case of major contralateral nonfatal stroke (0.5%), 10 cases of minor ischemic stroke (5%), 12 cases of transient ischemic attack (2%), and 2 cases of nonfatal myocardial infarction (1%).Conclusion: Patients with concurrent carotid and coronary artery disease may benefit from both hybrid revascularization by CAS-CAB and phased revascularization by CAS-CAB, which are feasible, safe, and provide good short-and long-term results.Our research suggests that CAS should be considered as a feasible alternative to open heart surgery.An adequately powered randomised experiment should compare the two approaches.